GPs should consider referring patients whose symptoms and signs may be due to cancer, but the tumour site is not clear, to the Non-Specific Symptom Pathway managed by your local Rapid Diagnostic Centre (RDC). A Site Specific Pathway remains appropriate if there is GP concern, but the tumour site of origin seems clear, even if […]
The Transforming Cancer Services Team and Elective Care Improvement Support Team have been supporting Integrated Care System (ICS) led demand and capacity (D&C) modelling for CT, MRI and ultrasound across North Central and North East London systems. The approach was initially developed with the Southwest London ICS using the national demand and capacity teams ‘Core […]
In light of recent challenges with nuclear medicine and PET-CT we have recently started a pan-London nuclear medicine group to support recruitment and development of staff in this specialist and under the radar discipline. We are beginning the process of hiring a pan-London practice educator as a first step in that support. The Imaging and […]
We have updated our on-line interactive dashboard to include 2021 cancer waiting times data. Analysis is provided at London, STP, Cancer Alliance and tumour level. Over the past ten years the number of patients seen as suspected cancer has increased each year, except during 2020 due to pandemic. Between 2012 and 2019 the number of […]
The National Cancer Patient Experience Survey (NCPES) is an important part of the national NHS Cancer Programme, which places patient experience on a par with clinical effectiveness and safety as a key strategic priority. It has been designed to monitor progress on cancer care, to drive local quality improvements, to assist commissioners and providers of […]
Quality of Life and Cancer continues to be a key priority area within the TCST Personalised Cancer Care programme. There is an established London Quality of Life and Cancer Working group and two established Task and Finish groups focusing on: Improving survey completeness across London and the Understanding the data and what it means for London.An action plan […]
Liz Price is working with the London and South East Sarcoma Network and specialised commissioning across East of England, South East England and London regarding the network’s sarcoma pathways. Sarcoma pathways include soft tissue, bone and gastrointestinal stromal tumours (GIST). At the moment, soft tissue pathways are struggling with capacity and demand for diagnostic services. […]
In 2019 and 2020, TCST cancer data team worked with national colleagues to develop two fantastic analytical tools a couple of years ago. Although the team aren’t responsible for updating these it is great to see them being updated and developed by national colleagues. The prevalence dashboard can be viewed via the NHS cancer data […]
We have updated our on-line interactive dashboard to include 2021 cancer waiting times data. Analysis is provided at London, STP, Cancer Alliance and tumour level. Over the past ten years the number of patients seen as suspected cancer has increased each year, except during 2020 due to pandemic. Between 2012 and 2019 the number of […]
Philippa Hyman and Liz Price from the Personalised Care team in TCST are working with North Central London and other interested stakeholders to understand the impact of psychological harm caused by waiting for cancer tests and treatment. One key aspect of this project will be to consider how best to assess the potential for psychological […]